Cargando…
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians
Fluid biomarkers improve the diagnostic accuracy in dementia and provide an objective measure potentially useful as a therapeutic response in clinical trials. The role of fluid biomarkers in patient care is a rapidly evolving field. Here, we provide a review and recommendations regarding the use of...
Autores principales: | Rosa-Neto, Pedro, Hsiung, Ging-Yuek Robin, Masellis, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980280/ https://www.ncbi.nlm.nih.gov/pubmed/24565514 http://dx.doi.org/10.1186/alzrt223 |
Ejemplares similares
-
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
por: Ismail, Zahinoor, et al.
Publicado: (2020) -
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
por: Gauthier, Serge, et al.
Publicado: (2012) -
Early-onset dementias: diagnostic and etiological considerations
por: Masellis, Mario, et al.
Publicado: (2013) -
Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Herrmann, Nathan, et al.
Publicado: (2013) -
Abstracts from the Canadian Consensus Conference on Dementia
por: Madden, Kenneth M.
Publicado: (2013)